Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Jeffrey S. Wisch"'
Autor:
Jeffrey A Meyerhardt, Sunil Kumar, Jessica A Zerillo, Aparna Parikh, James M Cleary, Scott Rodig, Benjamin Schlechter, Kimmie Ng, Stephanie K Dougan, Nora Horick, Glenn J Hanna, Andrew L Coveler, Anuj K Patel, Nadine J McCleary, Douglas A Rubinson, Jeffrey W Clark, Kent Mouw, Kathleen Pfaff, Thomas A Abrams, Matthew B Yurgelun, Eliezer M Van Allen, S Jennifer Wang, Leah H Biller, Harshabad Singh, Emma L Welsh, Brandon M Huffman, Lestat R Ali, Megan T Hoffman, Katherine A Metayer, Shayla Murray, Alexandra Bird, Jennifer A Chan, Wolfram Goessling, Jeffrey S Wisch, Brendan Reardon, Robert J Mayer, Catherine Del Vecchio Fitz, Charlotte Kuperwasser
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 1 (2024)
Background Recent trials suggest that programmed cell death 1 (PD-1)-directed immunotherapy may be beneficial for some patients with anal squamous cell carcinoma and biomarkers predictive of response are greatly needed.Methods This multicenter phase
Externí odkaz:
https://doaj.org/article/3355b66d86a3433d9514838bcb4205a5
Autor:
Rachel B. Keller, Tali Mazor, Lynette Sholl, Andrew J. Aguirre, Harshabad Singh, Nilay Sethi, Adam Bass, Ankur K. Nagaraja, Lauren K. Brais, Emma Hill, Connor Hennessey, Margaret Cusick, Catherine Del Vecchio Fitz, Zachary Zwiesler, Ethan Siegel, Andrea Ovalle, Pavel Trukhanov, Jason Hansel, Geoffrey I. Shapiro, Thomas A. Abrams, Leah H. Biller, Jennifer A. Chan, James M. Cleary, Steven M. Corsello, Andrea C. Enzinger, Peter C. Enzinger, Robert J. Mayer, Nadine J. McCleary, Jeffrey A. Meyerhardt, Kimmie Ng, Anuj K. Patel, Kimberley J. Perez, Osama E. Rahma, Douglas A. Rubinson, Jeffrey S. Wisch, Matthew B. Yurgelun, Michael J. Hassett, Laura MacConaill, Deborah Schrag, Ethan Cerami, Brian M. Wolpin, Jonathan A. Nowak, Marios Giannakis
Publikováno v:
JCO Precision Oncology.
PURPOSE With the growing number of available targeted therapeutics and molecular biomarkers, the optimal care of patients with cancer now depends on a comprehensive understanding of the rapidly evolving landscape of precision oncology, which can be c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::25b750fdb827491918b84d39feefb934
https://doi.org/10.1200/po.22.00342
https://doi.org/10.1200/po.22.00342
Publikováno v:
The Journal of community and supportive oncology. 12(3)
It's now more than 20 years since the government issued standards to reduce the risk for sharps injury that health care workers are exposed to in their daily working lives. The Occupational Safety and Health Administration (OSHA) issued the Bloodborn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ec31aaf1b39c5f052549ff97bde194b1
https://pubmed.ncbi.nlm.nih.gov/24971411
https://pubmed.ncbi.nlm.nih.gov/24971411
Autor:
Kenneth C. Anderson, Bradley Rivotto, Paul G. Richardson, Patrick Henrick, Alexandra Savell, Irene M. Ghobrial, Ashraf Badros, Rodrigo O. Maegawa, Jacalyn Rosenblatt, Saad Z. Usmani, Andrew Yee, James J. Vredenburgh, Claudia E. Paba-Prada, Jeffrey Matous, Charles M. Farber, Joseph Cappuccio, Kaitlen Reyes, Aaron M. Caola, Jeffrey S. Wisch, Robert L. Schlossman, Jacob P. Laubach, Kimberly Noonan, Nikhil C. Munshi
Publikováno v:
Blood. 128:976-976
Background This study aimed to determine the benefit of early therapeutic intervention with the combination of elotuzumab, Lenalidomide, and Dexamethasone in patients with high-risk smoldering multiple myeloma (SMM). ClinicalTrials.gov Identifier: NC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2ca28bd359a20761a9ca76d9fbc5eb18
https://doi.org/10.1182/blood.v128.22.976.976
https://doi.org/10.1182/blood.v128.22.976.976
Autor:
T J Gribble, Paige Kaplan, Rebecca S. Wappner, Edwin H. Kolodny, Joel Charrow, Neal J. Weinreb, J A Esplin, Gregory M. Pastores, C. R. Scott, Jeffrey S. Wisch
Publikováno v:
Archives of internal medicine. 158(16)
Background Timely diagnosis and continued monitoring of patients with type I Gaucher disease is critical because skeletal involvement can permanently disable patients and visceral organ involvement can lead to abdominal pain and secondary hematologic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4131fa3d3e74d595b55717c45edcf79
https://pubmed.ncbi.nlm.nih.gov/10371236
https://pubmed.ncbi.nlm.nih.gov/10371236
Autor:
Alice T. Mazur, Paige Kaplan, Neal J. Weinreb, T.John Gribble, Jeffrey S. Wisch, J. A. Esplin, Rebecca S. Wappner, Joel Charrow, Orly Manor
Publikováno v:
The Journal of pediatrics. 129(1)
OBJECTIVES: The incidence and severity of growth retardation in children with type 1 Gaucher disease and the response to enzyme replacement therapy with alglucerase were studied. STUDY DESIGN: A retrospective analysis of growth in 99 children and ado
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8e50ce78b3fd12a4c4cc387b56b6d55
https://pubmed.ncbi.nlm.nih.gov/8757576
https://pubmed.ncbi.nlm.nih.gov/8757576
Autor:
George P. Canellos, John F. Daley, Stuart F. Schlossman, Jeffrey S. Wisch, James D. Griffin, Heather Lane, Ramana Tantravahi, Ellis L. Reinherz, Richard P. Beveridge, Geoffrey Sherwood
Publikováno v:
Blood. 61:640-644
There is little evidence to suggest that T lymphocytes are involved in the leukemic process in chronic myeloid leukemia (CML). A case of CML in blast phase is described in which T-cell surface antigens were detected by immunofluorescence on the patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ad84fdc9ab71fbd749caca28137bfe55
https://doi.org/10.1182/blood.v61.4.640.640
https://doi.org/10.1182/blood.v61.4.640.640
Publikováno v:
New England Journal of Medicine. 309:1599-1602
Preleukemic syndromes are a group of acquired bone-marrow disorders characterized by dysplastic maturation of hematopoietic cells and peripheral-blood cytopenias. Although the clinical course is variable, most patients succumb to hemorrhage, infectio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47eeb928c37ee60c6fb286340032ef95
https://doi.org/10.1056/nejm198312293092602
https://doi.org/10.1056/nejm198312293092602
Publikováno v:
Blood. 65:1087-1089
Low doses of cytosine arabinoside (ara-C) have recently been administered by intravenous (IV) infusion and intermittent subcutaneous (SC) injection to patients with pre-leukemia and acute leukemia. Our studies have demonstrated that the continuous IV
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cbff00308d7c027e8321d691090717ff
https://doi.org/10.1182/blood.v65.5.1087.1087
https://doi.org/10.1182/blood.v65.5.1087.1087
Autor:
Jeffrey A. Gelfand, Charles A. Dinarello, Mark S. Drapkin, Jeffrey S. Wisch, Joseph G. Cannon
Publikováno v:
The Pediatric infectious disease journal. 8(6)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78b4080cac6e6d9a5f7659e75e052288
https://pubmed.ncbi.nlm.nih.gov/2501752
https://pubmed.ncbi.nlm.nih.gov/2501752